Study group puts the boot in over clinical trials' footprints Non-clinical study 26 January 2013 Pages: 2 - 2
Inadequate paediatric vaccination funding may put kids at risk Media release 26 January 2013 Pages: 4 - 4
Subsidised fitness programme a winner in diabetes management Clinical study 26 January 2013 Pages: 5 - 5
Schizophrenia treatment deviates from guidelines in Belgium Clinical study 26 January 2013 Pages: 6 - 6
Healthcare worker density a significant predictor of vaccination coverage News item 26 January 2013 Pages: 6 - 6
The use of complementary and alternative medicines (CAM) in New Zealand children aged ≪ 12 years is high, and disclosure rates low, Clinical study 26 January 2013 Pages: 6 - 6
Lanthanum carbonate cost effective for hyperphosphataemia Clinical study 26 January 2013 Pages: 6 - 6
Low compliance with VTE prevention guidelines “disturbing” Clinical study 26 January 2013 Pages: 9 - 9
The rate of inappropriate use of IV proton pump inhibitors in the hospital setting is high, Clinical study 26 January 2013 Pages: 9 - 9
The Portugese regulator, Infarmed, has revealed a new pricing policy that looks set to impact 2290 generic drugs, News item 26 January 2013 Pages: 10 - 10
The Croatian government is to pay for early-stage human epidermal growth factor receptor 2-positive breast cancer patients to receive Roche's Herceptin News item 26 January 2013 Pages: 11 - 11
Following a vote by Welsh assembly members, prescription charges in Wales have been scrapped News item 26 January 2013 Pages: 11 - 11
GlaxoSmithKline has priced Tykerb [lapatinib], its breast cancer agent, at a discount News item 26 January 2013 Pages: 11 - 11
Abbott and the WHO have agreed on a balanced approach to deliver Kaletra/Aluvia [lopinavir/ritonavir] Media release 26 January 2013 Pages: 11 - 11